qua., 14 de out. de 2026 · Imunidade
Purple coneflower
Echinacea purpurea
A prairie flower whose long healing history meets cautious modern research on colds and immune responses.
Onde atua no organismo
- Sistema imunitário
Sabedoria tradicional
A dar os primeiros passos na Ayurveda
These qualities describe one contemporary Ayurvedic interpretation, not a classical consensus: echinacea has no classical Ayurvedic use or prescribed preparation. Modern practitioners may use root powder or a kashaya-style decoction, interpreting its bitter, drying character as reducing pitta and kapha while potentially aggravating vata.
Sabor (rasa)
Equilíbrio dos doshas
Entre tradições
Contemporary Ayurvedic herbalists sometimes place echinacea among bitter, cooling herbs used for inflammatory or suppurative conditions. This is a modern application of Ayurvedic principles to an introduced plant, rather than an inherited Sanskrit materia-medica entry.
Ritual de atenção plena
If echinacea is appropriate for you, prepare a small cup according to a reputable product's directions and pause for three unhurried breaths before sipping. Notice the earthy bitterness without treating a stronger taste as a reason to take more.
Compostos ativos
- Alkamides
- Cichoric acid
- Polysaccharides
- Caftaric acid
Investigação moderna
De perto
Onde cresce
É seguro para mim?
Sobre a planta
Purple coneflower is a perennial member of the daisy family, native to central and eastern North America. It grows in prairies, open woodland, and sunny clearings and is widely cultivated as an ornamental and medicinal herb.
Its sturdy stems bear rough, broad leaves and pink-purple flower heads surrounding a raised, spiny orange-brown cone. Medicinal preparations use the roots, aboveground parts, or both; their chemical composition varies with the plant part and processing method.
A descoberta
Several Indigenous peoples of North America used Echinacea species for ailments including toothache, sore throat, wounds, and infections. Much of the historical record concerns related species, especially Echinacea angustifolia, so it should not all be attributed to purple coneflower. Echinacea entered nineteenth-century American medical practice, and twentieth-century European cultivation and research helped popularize E. purpurea preparations. Its present reputation for immune support grew from this traditional use, laboratory studies of immune activity, and clinical trials investigating respiratory infections.
Usos tradicionais
- Sore throat and respiratory complaints, within the broader history of Echinacea use.
- Toothache and mouth discomfort, particularly with related Echinacea species.
- Topical treatment of wounds and skin complaints.
- More recently, prevention or early treatment of common colds.
Detalhes da investigação
Echinacea may slightly reduce the likelihood of catching a cold. · Moderado
In the rhinovirus trial, colds developed in 58% of echinacea recipients versus 82% receiving placebo, but the difference was not statistically significant; infection rates were similar (92% versus 95%). Another human trial measured respiratory infection incidence, but its supplied excerpt omits the results, so a preventive benefit remains uncertain.
Taking echinacea after cold symptoms begin shortens or eases the illness. · Preliminar
The pharmacology review describes alleviation of cold symptoms, but the supplied excerpt provides no trial results establishing that starting echinacea after symptoms appear shortens or eases illness. The claim is therefore not established by the supplied evidence.
Echinacea broadly strengthens immunity. · Preliminar
Reviews describe immunostimulatory properties, traditional immune-related uses, and effects on nonspecific cellular immunity, while a chicken study reports altered cytokine gene expression and reduced oxidative stress. The human mucosal-immunity trial's supplied excerpt omits its immune outcomes, so these sources do not establish broad immune strengthening in people.
Como se utiliza
- If trying it for a cold, choose a product that identifies Echinacea purpurea, the plant part, and the extract strength. Findings from one preparation may not apply to another.
- Follow the product label rather than assuming that capsules, tinctures, juices, and teas provide equivalent doses; no universally established effective dose exists.
- Keep use short-term unless a clinician advises otherwise. Seek medical care for breathing difficulty, dehydration, persistent fever, or worsening symptoms rather than relying on an herbal product.
Segurança
- Short-term oral use is generally well tolerated by many adults; nausea, abdominal discomfort, and rash can occur.
- Allergic reactions can occasionally be severe. Use particular caution with allergy to plants in the daisy family, such as ragweed, chrysanthemums, or daisies.
- People with autoimmune disease, an organ transplant, or significant immune-system disorders should consult their treating clinician before use because immune effects are incompletely understood.
- Evidence on safety during pregnancy and breastfeeding is limited. Consult a clinician before use in these circumstances or in children; some pediatric studies have reported increased rash.
Interações medicamentosas
- Immunosuppressants, including transplant medicines: echinacea could theoretically interfere with treatment through immune-modulating effects; clinical interaction evidence is limited, but unsupervised use is inadvisable.
- Medicines processed by liver enzymes such as CYP3A4 or CYP1A2: small human studies show variable effects on drug metabolism. Ask a pharmacist to check compatibility, especially for medicines with a narrow safety margin.
Fontes
Elaborado a partir de 12 fontes, escolhidas por regras fixas, não pela IA.
Estudos em humanos
- [1]Echinacea purpurea supplementation does not enhance VO2max in distance runners
Journal of strength and conditioning research · 2014
EnsaioMotivo: Randomised human trial, 2014, older classic, human data - [2]Echinacea purpurea and mucosal immunity
International journal of sports medicine · 2007
EnsaioMotivo: Randomised human trial, 2007, older classic, human data - [3]Echinacea purpurea for prevention of experimental rhinovirus colds
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2004
EnsaioMotivo: Randomised human trial, 2004, older classic, human data - [4]Echinacea purpurea: Pharmacology, phytochemistry and analysis methods
Pharmacognosy reviews · 2015
Estudo em humanosMotivo: Human study, 2015, older classic, human data
Revisões e investigação laboratorial
- [5]Efficacy of traditional herbal formulas on human immunity
European review for medical and pharmacological sciences · 2023
RevisãoMotivo: Expert review, 2023, recent, not in people - [6]Antiviral activity of medicinal plant-derived products against SARS-CoV-2
Experimental biology and medicine (Maywood, N.J.) · 2022
RevisãoMotivo: Expert review, 2022, recent, not in people - [7]Echinacea purpurea (L.) Moench: Biological and Pharmacological Properties. A Review
Plants (Basel, Switzerland) · 2022
RevisãoMotivo: Expert review, 2022, recent, not in people - [8]Echinacea plants as antioxidant and antibacterial agents: From traditional medicine to biotechnological applications
Phytotherapy research : PTR · 2018
RevisãoMotivo: Expert review, 2018, recent, not in people - [9]Review and Assessment of Medicinal Safety Data of Orally Used Echinacea Preparations
Planta medica · 2016
RevisãoMotivo: Expert review, 2016, recent, not in people - [10][Echinacea drugs--effects and active ingredients]
Zeitschrift fur arztliche Fortbildung · 1996
RevisãoMotivo: Expert review, 1996, older classic, not in people - [11]Dietary Echinacea purpurea Attenuates Oxidative Stress and Alters Cytokine Gene Expression Among Heat-Stressed Broiler Chickens at High Altitude
Veterinary medicine and science · 2026
Laboratório / animaisMotivo: Lab or animal study, 2026, recent, not in people - [12]Organ-Resolved Salicylate-Phenylpropanoid Metabolite Profiling of <i>Echinacea purpurea</i>, <i>E. pallida</i>, and <i>E. tennesseensis</i> Tissues Extracted with 50% Aqueous Methanol by LC-MS/MS and LC-HRMS
Molecules (Basel, Switzerland) · 2026
Laboratório / animaisMotivo: Lab or animal study, 2026, recent, not in people
Porquê estas fontes?
- A planta certa. Tem de indicar o nome latino exato da espécie. Nomes comuns como «ginseng» abrangem várias plantas.
- Tipo de estudo com maior evidência primeiro. Meta-análises, seguidas de ensaios aleatorizados em humanos, outros estudos em humanos, revisões, estudos laboratoriais e em animais e, por fim, enciclopédias.
- Mais recentes primeiro. Em cada categoria, os artigos mais recentes aparecem primeiro. Os clássicos mais antigos estão identificados como tal.
- Pessoas antes de tubos de ensaio. Uma alegação só pode ter evidência Forte ou Moderada se for apoiada por um estudo em humanos. Resultados apenas de laboratório ou em animais são sempre Preliminares.
- Credíveis e não retratados. Apenas artigos revistos por pares e indexados no PubMed ou Europe PMC. Os artigos retratados são removidos.
- Equilibrado. Os estudos que não encontraram efeito são mantidos e reduzem o nível de evidência.
- Limitada e heterogénea. No máximo, 12 fontes por planta e 3 da mesma revista científica.
Consulte as fontes
Esta informação é educativa e não constitui aconselhamento médico. As plantas medicinais podem interagir com medicamentos e não substituem o tratamento. Fale com o seu médico antes de usar qualquer planta para um problema de saúde.
Como se descobriu isto?